title: Combining several interventions to reduce the incidence of OHSS: A prospective cohort study.
abstract: OBJECTIVE
  To assess the outcome of using low-dose aspirin, dopamine agonist and triggering ovulation by low dose of HCG in combination with GnRH agonist in fixed GnRH antagonist protocol in patients at risk of OHSS.
  
  
  METHODS
  This prospective cohort study was conducted on 50 infertile women who were at high risk of OHSS. They received low dose aspirin from first day of stimulation, cabergoline 0.5mg daily from the day of HCG for 8days and low dose of HCG (2500 IU) in combination with GnRH agonist for final oocyte maturation in fixed GnRH antagonist protocol.
  
  
  RESULTS
  The study was conducted on 50 cases and all of them completed the study protocol. The clinical pregnancy rate was 40% (20 cases of 50) and no cases developed severe or critical OHSS. Only 8% (4 cases) developed moderate OHSS.
  
  
  CONCLUSIONS
  Combining aspirin, cabergoline, and triggering with low dose of HCG in combination with GnRH agonist produced excellent clinical pregnancy rate, and decreased hospital admissions with severe or critical OHSS.
authors.affiliation: Obstetrics and Gynecology department, Faculty of Medicine, Alexandria University, Egypt. Electronic address: mahdy_moh@yahoo.com.
authors.forename: Mohamed
authors.initials: M
authors.lastname: Elmahdy
authors.affiliation: Obstetrics and Gynecology department, Faculty of Medicine, Alexandria University, Egypt.
authors.forename: Eman A
authors.initials: EA
authors.lastname: Abdelsalam
authors.affiliation: Obstetrics and Gynecology department, Faculty of Medicine, Alexandria University, Egypt.
authors.forename: Hassan A
authors.initials: HA
authors.lastname: Maghraby
mesh_terms: D000328:Adult; D001241:Aspirin / Q000008:administration & dosage*; D000077465:Cabergoline; D006063:Chorionic Gonadotropin / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000008:administration & dosage*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D007247:Infertility, Female / Q000628:therapy; D016471:Ovarian Hyperstimulation Syndrome / Q000517:prevention & control*; D010062:Ovulation Induction / Q000009:adverse effects; D011247:Pregnancy; D018873:Pregnancy Rate; D012102:Reproductive Control Agents / Q000008:administration & dosage*; D012720:Severity of Illness Index
chemical_list: D006063:Chorionic Gonadotropin; D004873:Ergolines; D012102:Reproductive Control Agents; D007987:Gonadotropin-Releasing Hormone; D000077465:Cabergoline; D001241:Aspirin
keywords: Antagonist protocol; Cabergoline; GnRH triggering; ICSI; OHSS